US Patent Issued to UCB Biopharma on June 2 for "Dicyclopropylmethyl derivatives as IL-17 modulators" (British Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,896, issued on June 2, was assigned to UCB Biopharma SRL (Brussels).

"Dicyclopropylmethyl derivatives as IL-17 modulators" was invented by James Richard Frost (Slough, Great Britain), Gregory William Haslett (Slough, Great Britain) and James Thomas Reuberson (Slough, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "A series of substituted dicyclopropyl methyl derivatives as defined herein, being potent modulators of human IL-17 activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including inflammatory and autoimmune disorders."

The patent was filed on Nov. 1, 2021, under Application No. 18/0...